Brofestill, 0.9 mg/mL, eye drops, solution
Bromfenac
Brofestill contains bromfenac, which belongs to a group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs). It works by blocking certain substances that cause inflammation.
Brofestill is used to reduce inflammation of the eye after cataract surgery in adults.
Before starting to use Brofestill, discuss it with your doctor or pharmacist.
It is not recommended to wear contact lenses after cataract surgery. For this reason, do not wear contact lenses while using Brofestill.
Brofestill should not be used in children and adolescents.
Tell your doctor or pharmacist about all medicines you are taking or have recently taken, as well as any medicines you plan to take.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, ask your doctor for advice before using this medicine.
Brofestill should not be used during the last three months of pregnancy.
Your doctor may prescribe this medicine during pregnancy if the expected benefit to the mother outweighs the potential risk to the baby.
Brofestill can be prescribed to a breastfeeding woman and has no significant effect on fertility.
For a short time after using the medicine, blurred vision may occur. Patients experiencing decreased visual acuity after using the medicine should not drive or operate machines until these symptoms have resolved.
The medicine contains 0.00185 mg of benzalkonium chloride in each drop, which corresponds to 0.05 mg/mL.
Benzalkonium chloride may be absorbed by soft contact lenses and change their color. Remove contact lenses before instillation and wait at least 15 minutes before reinserting.
Benzalkonium chloride may also cause eye irritation, especially in people with dry eye syndrome or corneal disorders (the transparent layer at the front of the eye). If you experience any abnormal sensations in the eye, stinging, or pain in the eye after using the medicine, contact your doctor.
This medicine should always be used exactly as your doctor or pharmacist has told you. If you are not sure, ask your doctor or pharmacist.
Dose
The recommended dose is one drop of Brofestill into the affected eye(s) twice daily (morning and evening). Do not use more than one drop into the affected eye(s) twice daily.
Start using Brofestill the day after cataract surgery.
Method of administration
Brofestill is for use in the eye.
If you are using other eye drops, wait 5 minutes between using Brofestill and other eye drops.
Duration of treatment
Use the drops for 2 weeks after surgery. Do not use Brofestill for more than 2 weeks.
Rinse your eye with warm water. Do not use any more drops until the next dose is due. If you accidentally swallow Brofestill, drink a glass of water or other liquid to rinse out the medicine.
Use a single dose as soon as you remember. If it is almost time for the next dose, skip the missed dose. Continue using the medicine as before. Do not use a double dose to make up for a missed dose.
Do not stop using Brofestill without talking to your doctor.
In rare cases, after stopping Brofestill, an increase in inflammatory reactions has been observed after cataract surgery, e.g., in the form of macular edema.
If you have any further questions about using this medicine, ask your doctor or pharmacist.
Like all medicines, Brofestill can cause side effects, although not everybody gets them.
If you experience worsening vision or decreased visual acuity after one week of finishing treatment, contact your doctor immediately.
If you notice any of the following side effects while using the drops, contact your doctor immediately:
Feeling of a foreign body in the eye, redness and inflammation of the eye, damage and inflammation of the eye surface, discharge from the eye, itching, irritation, or pain in the eye, swelling or bleeding of the eyelid, impaired vision due to inflammation, floaters or moving points before the eyes, or worsening vision that may indicate bleeding or damage to the back of the eye (retina), eye discomfort, sensitivity to light, blurred or decreased vision, facial swelling, cough, nosebleed, or runny nose.
Damage to the eye surface, redness of the eye, asthma.
If you experience any side effects, including any not listed in this leaflet, tell your doctor or pharmacist. You can also report side effects directly to the Department of Monitoring of Adverse Reactions to Medicinal Products, Medical Devices, and Biocides, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309. Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep the medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the bottle after "EXP". The expiry date refers to the last day of the month.
Do not store above 25°C. Do not freeze.
Discard the bottle after 4 weeks of first opening to prevent infection, even if there is still solution left in the bottle.
Write the date of opening on the carton in the space provided.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
A 5 mL solution bottle with LDPE dropper, PP cap, and tamper-evident closure, in a cardboard box
Pharm Supply Sp. z o.o.
ul. Marconich 2/9,
02-954 Warsaw
tel: +48 (22) 642 33 31
e-mail: kontakt@pharmsupply.com.pl
Genetic S.p.A.
Contrada Canfora, 84084 Fisciano (SA)
Italy
BRO multi ver 22 07 2024
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.